Since those were not systematic reviews, the authors used less strict criteria for inclusion, while this study aimed at demonstrating the correlation between CD36 and the prognosis of AML by evaluating clinical and not pre-clinical studies. Here, CD36 is linked to acute myeloid leukemia.